到 Westmead 呼吸困难服务机构就诊的慢性阻塞性肺病患者的症状负担:患病率、关联性和性别差异。

IF 2.7 3区 医学 Q2 RESPIRATORY SYSTEM
Mary Roberts, Tracy Smith, John Wheatley, Jin-Gun Cho
{"title":"到 Westmead 呼吸困难服务机构就诊的慢性阻塞性肺病患者的症状负担:患病率、关联性和性别差异。","authors":"Mary Roberts, Tracy Smith, John Wheatley, Jin-Gun Cho","doi":"10.2147/COPD.S433541","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Chronic obstructive pulmonary disease (COPD) is a progressive disease resulting in a range of symptoms including breathlessness. \"Symptom burden\" describes the severity and impact of multiple symptoms in an individual and is best quantified using validated symptom instruments but is not routinely measured in clinical practice. Therefore, we wanted to assess overall symptom burden in patients with moderate-to-severe COPD and find associated independent predictors.</p><p><strong>Patients and methods: </strong>A single-centre cross-sectional study of patients with COPD who attended the Westmead Breathlessness Service between March 2017 and May 2022 was conducted. We obtained baseline demographic data, lung function, assessed quality of life (CAT), anxiety/depression (HADS), and measured symptom burden (CMSAS). We compared variables between men and women using unpaired t tests or Mann-Whitney tests for continuous variables, and Fisher's exact tests for categorical variables. We used multiple regression to look for independent predictors of overall symptom burden. Data were analysed using Stata/IC 15.1.</p><p><strong>Results: </strong>Eighty-nine patients with COPD, mean age 72.6 years, 55% male, mean FEV<sub>1</sub> 32% predicted, reported an average of 8.9 symptoms including 6.9 physical and 1.6 psychological symptoms. The most common physical symptoms were shortness of breath (100%) and lack of energy (80%), and the most common psychological symptoms were worrying (65%) and feeling anxious (61%). Median CMSAS total score was higher in women than men (1.34 versus 1.04, respectively; <i>p</i>=0.03) with more women experiencing nervousness (<i>p</i>=0.011) and anxiety (<i>p</i>=0.005). Female sex (<i>p</i>=0.003), HADS-Anxiety (<i>p</i>=0.0001), and HADS-Depression (<i>p</i>=0.0001) were independently associated with total CMSAS score in a multiple linear regression model and explained 63% of total CMSAS variability.</p><p><strong>Conclusion: </strong>Very high physical and psychological symptom burden exists among patients with severe COPD. Anxiety, depression, and female sex were independently associated with increasing symptom burden. Identifying and understanding sex differences for COPD symptoms, and interventions targeting anxiety and depression may help to reduce overall symptom burden within this population.</p>","PeriodicalId":48818,"journal":{"name":"International Journal of Chronic Obstructive Pulmonary Disease","volume":"18 ","pages":"2825-2837"},"PeriodicalIF":2.7000,"publicationDate":"2023-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695132/pdf/","citationCount":"0","resultStr":"{\"title\":\"Symptom Burden of Patients with Chronic Obstructive Pulmonary Disease Attending the Westmead Breathlessness Service: Prevalence, Associations, and Sex-Related Differences.\",\"authors\":\"Mary Roberts, Tracy Smith, John Wheatley, Jin-Gun Cho\",\"doi\":\"10.2147/COPD.S433541\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>Chronic obstructive pulmonary disease (COPD) is a progressive disease resulting in a range of symptoms including breathlessness. \\\"Symptom burden\\\" describes the severity and impact of multiple symptoms in an individual and is best quantified using validated symptom instruments but is not routinely measured in clinical practice. Therefore, we wanted to assess overall symptom burden in patients with moderate-to-severe COPD and find associated independent predictors.</p><p><strong>Patients and methods: </strong>A single-centre cross-sectional study of patients with COPD who attended the Westmead Breathlessness Service between March 2017 and May 2022 was conducted. We obtained baseline demographic data, lung function, assessed quality of life (CAT), anxiety/depression (HADS), and measured symptom burden (CMSAS). We compared variables between men and women using unpaired t tests or Mann-Whitney tests for continuous variables, and Fisher's exact tests for categorical variables. We used multiple regression to look for independent predictors of overall symptom burden. Data were analysed using Stata/IC 15.1.</p><p><strong>Results: </strong>Eighty-nine patients with COPD, mean age 72.6 years, 55% male, mean FEV<sub>1</sub> 32% predicted, reported an average of 8.9 symptoms including 6.9 physical and 1.6 psychological symptoms. The most common physical symptoms were shortness of breath (100%) and lack of energy (80%), and the most common psychological symptoms were worrying (65%) and feeling anxious (61%). Median CMSAS total score was higher in women than men (1.34 versus 1.04, respectively; <i>p</i>=0.03) with more women experiencing nervousness (<i>p</i>=0.011) and anxiety (<i>p</i>=0.005). Female sex (<i>p</i>=0.003), HADS-Anxiety (<i>p</i>=0.0001), and HADS-Depression (<i>p</i>=0.0001) were independently associated with total CMSAS score in a multiple linear regression model and explained 63% of total CMSAS variability.</p><p><strong>Conclusion: </strong>Very high physical and psychological symptom burden exists among patients with severe COPD. Anxiety, depression, and female sex were independently associated with increasing symptom burden. Identifying and understanding sex differences for COPD symptoms, and interventions targeting anxiety and depression may help to reduce overall symptom burden within this population.</p>\",\"PeriodicalId\":48818,\"journal\":{\"name\":\"International Journal of Chronic Obstructive Pulmonary Disease\",\"volume\":\"18 \",\"pages\":\"2825-2837\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2023-11-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695132/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Chronic Obstructive Pulmonary Disease\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2147/COPD.S433541\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"RESPIRATORY SYSTEM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Chronic Obstructive Pulmonary Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/COPD.S433541","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

摘要

目的:慢性阻塞性肺疾病(COPD)是一种进展性疾病,会导致包括呼吸困难在内的一系列症状。"症状负担 "描述了个人多种症状的严重程度和影响,最好使用经过验证的症状工具进行量化,但在临床实践中并未进行常规测量。因此,我们希望评估中度至重度慢性阻塞性肺病患者的总体症状负担,并找到相关的独立预测因素:我们对2017年3月至2022年5月期间接受韦斯特米德呼吸困难服务的慢性阻塞性肺病患者进行了一项单中心横断面研究。我们获得了基线人口统计学数据、肺功能,评估了生活质量(CAT)、焦虑/抑郁(HADS),并测量了症状负担(CMSAS)。对于连续变量,我们使用非配对 t 检验或曼-惠特尼检验来比较男女之间的变量;对于分类变量,我们使用费雪精确检验来比较男女之间的变量。我们使用多元回归法寻找总体症状负担的独立预测因素。数据使用 Stata/IC 15.1 进行分析:89 名慢性阻塞性肺病患者(平均年龄 72.6 岁,55% 为男性,平均 FEV1 预测值为 32%)平均报告了 8.9 种症状,其中包括 6.9 种躯体症状和 1.6 种心理症状。最常见的生理症状是气短(100%)和乏力(80%),最常见的心理症状是担心(65%)和焦虑(61%)。女性的 CMSAS 总分中位数高于男性(分别为 1.34 和 1.04;P=0.03),更多女性感到紧张(P=0.011)和焦虑(P=0.005)。在多元线性回归模型中,女性性别(p=0.003)、HADS-焦虑(p=0.0001)和 HADS-抑郁(p=0.0001)与 CMSAS 总分独立相关,并解释了 CMSAS 总变异的 63%:结论:严重慢性阻塞性肺病患者的生理和心理症状负担非常重。焦虑、抑郁和女性性别与症状负担的增加密切相关。识别和了解慢性阻塞性肺病症状的性别差异以及针对焦虑和抑郁的干预措施可能有助于减轻该人群的总体症状负担。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Symptom Burden of Patients with Chronic Obstructive Pulmonary Disease Attending the Westmead Breathlessness Service: Prevalence, Associations, and Sex-Related Differences.

Purpose: Chronic obstructive pulmonary disease (COPD) is a progressive disease resulting in a range of symptoms including breathlessness. "Symptom burden" describes the severity and impact of multiple symptoms in an individual and is best quantified using validated symptom instruments but is not routinely measured in clinical practice. Therefore, we wanted to assess overall symptom burden in patients with moderate-to-severe COPD and find associated independent predictors.

Patients and methods: A single-centre cross-sectional study of patients with COPD who attended the Westmead Breathlessness Service between March 2017 and May 2022 was conducted. We obtained baseline demographic data, lung function, assessed quality of life (CAT), anxiety/depression (HADS), and measured symptom burden (CMSAS). We compared variables between men and women using unpaired t tests or Mann-Whitney tests for continuous variables, and Fisher's exact tests for categorical variables. We used multiple regression to look for independent predictors of overall symptom burden. Data were analysed using Stata/IC 15.1.

Results: Eighty-nine patients with COPD, mean age 72.6 years, 55% male, mean FEV1 32% predicted, reported an average of 8.9 symptoms including 6.9 physical and 1.6 psychological symptoms. The most common physical symptoms were shortness of breath (100%) and lack of energy (80%), and the most common psychological symptoms were worrying (65%) and feeling anxious (61%). Median CMSAS total score was higher in women than men (1.34 versus 1.04, respectively; p=0.03) with more women experiencing nervousness (p=0.011) and anxiety (p=0.005). Female sex (p=0.003), HADS-Anxiety (p=0.0001), and HADS-Depression (p=0.0001) were independently associated with total CMSAS score in a multiple linear regression model and explained 63% of total CMSAS variability.

Conclusion: Very high physical and psychological symptom burden exists among patients with severe COPD. Anxiety, depression, and female sex were independently associated with increasing symptom burden. Identifying and understanding sex differences for COPD symptoms, and interventions targeting anxiety and depression may help to reduce overall symptom burden within this population.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
4.80
自引率
10.70%
发文量
372
审稿时长
16 weeks
期刊介绍: An international, peer-reviewed journal of therapeutics and pharmacology focusing on concise rapid reporting of clinical studies and reviews in COPD. Special focus will be given to the pathophysiological processes underlying the disease, intervention programs, patient focused education, and self management protocols. This journal is directed at specialists and healthcare professionals
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信